Superworth

Shoulder Innovations profit margin SI

Gross, operating and net profit as a share of revenue over the last twelve months, from 2024.

Net margin, 12 months
−58.3%
Operating margin, 12 months
−58.5%
Net margin on a year earlier
+26.6 pts
Peer median
7.8%

Over the twelve months to Jun 30, 2026, Shoulder Innovations kept −58.3% of its revenue as net profit, with an operating margin of −58.5% and a gross margin of 77.3%.

The median for 10 medical instruments and supplies stocks of a similar size is 7.8%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−85.3%−55.6%76.5%
FY2024−49.4%−46.3%77.0%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−58.3%+26.6 pts−58.5%
Q1 FY26−81.8%−33.5 pts−57.5%
Q4 FY25−85.3%−35.9 pts−55.6%
Q3 FY25−87.4%n/a−51.2%
Q2 FY25−84.9%n/a−47.1%
Q1 FY25−48.3%n/a−45.4%
Q4 FY24−49.4%n/a−46.3%
Q3 FY24n/an/an/a
Q2 FY24n/an/an/a
Q1 FY24n/an/an/a

Against its peers

Companies in Medical - Instruments & Supplies nearest Shoulder Innovations' size, closest first, today.

CompanyProfit margin
SIShoulder Innovations−58.3%
EMBCEmbecta8.6%
TCMDTactile Systems Technology7.1%
MDXGMimedx1.8%
INFUInfuSystem6.0%
MOVMovado6.0%
UTMDUtah Medical Products29.0%
PDEXPro DEX17.6%
IRMDIradimed26.7%
STAAStaar Surgical1.1%
BVSBioventus9.4%
Peer median7.8%

Where Shoulder Innovations ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Shoulder Innovations

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.